Novartis, World Bank Invest in BVCF’s $188 Million China Life Science Fund
April 10, 2014 at 05:39 AM EDT
As ChinaBio® Today reported, BVCF officially closed its third China life science fund, BCVF III, with $188 million in capital. BVCF III follows two earlier funds, which raised $21 million (2005) and $90 million (2008). The latest fund has already made investments, and its list of international blue-chip investors, which include Novartis and the World Bank, was also disclosed. BCVF was originally known as BioVeda China. More details....